{"id":"W1984096754","doi":"10.1124/jpet.102.046268","title":"N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain","year":2003,"lang":"en","type":"article","venue":"Journal of Pharmacology and Experimental Therapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Capsaicin; Hyperalgesia; Capsazepine; Chemistry; Antagonist; Nociception; Pharmacology; Neuropathic pain; Allodynia; Sciatic nerve; TRPV1; Receptor antagonist; Analgesic; Neurogenic inflammation; Endocrinology; Internal medicine; Receptor; Medicine; Transient receptor potential channel; Substance P; Biochemistry; Neuropeptide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000155609,0.0004183292,0.0004418397,0.0002853446,0.0001579056,0.0001583101,0.000365916,0.0003261975,0.001201051],"category_scores_gemma":[0.0001537331,0.0001933153,0.0001569147,0.0001702118,0.0002037842,0.0003446373,0.0001287505,0.000638672,0.0005909483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001742746,"about_ca_system_score_gemma":0.0003585472,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001166851,"about_ca_topic_score_gemma":0.002125916,"domain_scores_codex":[0.9999108,0.00001179918,0.000005597178,0.00001169763,0.00002556996,0.00003448886],"domain_scores_gemma":[0.9999239,0.00001157807,0.00002116781,0.000005796766,0.00001278085,0.00002475379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003757281,0.00008801656,0.00005214207,0.00008587481,0.000003536033,0.00004824759,0.000006585472,0.00004684597,0.9956858,0.00003951245,0.0000706587,0.003497079],"study_design_scores_gemma":[0.0004117913,0.006328279,0.004457636,0.00001899375,0.00006280417,0.001043157,0.00002393605,0.0008054562,0.9821544,0.00004317048,0.004633841,0.00001659856],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9673066,0.01416111,0.01060858,0.0004010006,0.0001389938,0.0003459339,0.0006648744,0.0002310524,0.006141986],"genre_scores_gemma":[0.9755511,0.01073373,0.007293666,0.0001628691,0.0001212443,0.0001832322,0.0009238326,0.00003322008,0.004997072],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001201051,"threshold_uncertainty_score":0.004017949,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01660227110757358,"score_gpt":0.2691521557036838,"score_spread":0.2525498845961102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}